36
Participants
Start Date
October 1, 2024
Primary Completion Date
April 30, 2027
Study Completion Date
July 30, 2027
PD-L1 antibody
1200mg intravenously every 3 weeks
Bevacizumab
15mg/kg intravenously every 3 weeks
HAIC-FOLFOX
Oxaliplatin 130 mg/m² via hepatic arterial infusion over 3 hours Leucovorin 400 mg/m² via hepatic arterial infusion over 2 hours Fluorouracil 400 mg/m² bolus via hepatic arterial infusion at hour 5, followed by 2400 mg/m² continuous hepatic arterial infusion over 46 hours HAIC treatment repeats every 3 weeks for up to 6 cycles
RECRUITING
West China Hospital, Chengdu
West China Hospital
OTHER